Description
Product Summary Table
| Name | CJC 1295 with DAC |
| Molar Mass | 3367.9 g/mol |
| Chemical Formula | C165H269N47O46 |
| IUPAC Name | L-tyrosyl-D-alanyl-L-alpha-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-arginyl-L-alpha-aspartyl-L-lysyl-L-tyrosyl-L-seryl-L-alpha-aspartyl-L-leucyl-L-arginyl-L-alpha-aspartyl-L-glutaminyl-L-lysyl-L-isoleucyl-L-prolyl-L-leucyl-L-glutaminyl-L-threonyl-L-lysyl-L-seryl-L-alpha-aspartyl-L-seryl-L-lysyl-L-glutaminyl-L-threonyl-L-lysyl-L-seryl-L-alpha-aspartyl-L-lysyl-L-seryl-L-alpha-aspartyl-L-lysyl-L-tyrosyl-D-alanyl-L-alpha-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-arginyl-L-alpha-aspartyl-L-lysyl-L-tyrosyl-L-seryl-L-alpha-aspartyl-L-leucyl-L-arginyl-L-alpha-aspartyl-L-glutaminyl-L-lysyl-L-isoleucyl-L-prolyl-L-leucyl-L-glutaminyl-L-threonyl-L-lysyl-L-seryl |
| Synonyms | CJC 1295 DAC, Modified GRF 1-29 |
| Country of Origin | USA |
| Storage | Reconstituted protein can be stored at between 1-4°C. |
| Standard | Research Purity ≥99% |
CJC 1295 DAC (Drug Affinity Complex) is a long-acting peptide designed to stimulate growth hormone release through selective pituitary activation. Unlike other peptides requiring frequent administration, CJC 1295 DAC boasts a unique extended half-life, allowing for convenient dosing with sustained results. Available for research through biotechpeps, CJC 1295 DAC is highly valued in clinical studies for muscle growth, fat reduction, and overall body composition improvements.
In Vivo Research Benefits
- Optimised Growth Hormone Release: CJC 1295 DAC stimulates the body’s natural growth hormone levels without harsh peaks, supporting a steady, controlled increase that favours muscle development and fat metabolism over time.
- Enhanced Muscle Mass and Recovery: In vivo studies indicate that CJC 1295 DAC aids significantly in muscle mass gains and recovery rates, enabling intensive training with enhanced tissue repair and regeneration.
- Improved Body Composition: Research shows that CJC 1295 DAC is effective in enhancing lean body mass while reducing adipose tissue, making it an attractive choice for those researching body composition optimisation.
- Extended Half-Life for Convenient Dosing: CJC 1295 DAC’s long half-life reduces the need for frequent administration, making it particularly suited to structured, long-term studies on growth hormone modulation and its effects.
Dosage and Administration
Dosage: Typically, CJC 1295 DAC can be administered once or twice weekly due to its prolonged half-life, which supports sustained GH release. Form: Injectable Solution Usage: Administer according to in vivo research protocols to observe anabolic, recovery, and body composition effects in subjects. As a potent GHRH analogue, CJC 1295 DAC allows researchers to explore growth hormone benefits with minimal dosing frequency.
Reviews
There are no reviews yet.